Advances in Immunology
Advances in Immunology Series, Vol. 86

Coordinator: Alt Frederick W.

Language: Anglais
Cover of the book Advances in Immunology

Subject for Advances in Immunology

171.65 €

In Print (Delivery period: 14 days).

Add to cartAdd to cart
Publication date:
336 p. · 15.2x22.9 cm · Hardback
Advances in Immunology, a long established and highly respected publication, presents current developments as well as comprehensive reviews in immunology. Articles address the wide range of topics that comprise immunology, including molecular and cellular activation mechanisms, phylogeny and molecular evolution, and clinical modalities. Edited and authored by the foremost scientists in the field, each volume provides up-to-date information and directions for future research.

* NOW AVAILABLE ONLINE!
* Highly respected review series with an impact factor in 2003 of of 7.424 and ranked number 8/114
* New Editor, Frederick Alt
Adenosine Deaminase Deficiency: Metabolic Basis of Immune Deficiency and Pulmonary Inflammation
Mechanism and Control of V(D)J Recombination Versus Class Switch Recombination: Similarities and Differences
Isoforms of Terminal deoxynucleotidyl transferase: Developmental aspects and function
Innate Autoimmunity
Formation of Bradykinin: A Major Contributor to the Innate Inflammatory Response
IL-2, IL-15 and Their Roles in Human Natural Killer Cells
Regulation of Antigen Presentation and Cross-presentation in the Dendritic Cell Network: Facts, Hypothesis, and Immunological Implications
Immunologists, infectious disease specialists, cell biologists and hematologists
Frederick W. Alt is a Howard Hughes Medical Institute (HHMI) Investigator and Director of the Program in Cellular and Molecular Medicine (PCMM) at Boston Children's Hospital (BCH). He is the Charles A. Janeway Professor of Pediatrics and Professor of Genetics at Harvard Medical School. He works on elucidating mechanisms that generate antigen receptor diversity and, more generally, on mechanisms that generate and suppress genomic instability in mammalian cells, with a focus on the immune and nervous systems. Recently, his group has developed senstive genome-wide approaches to identify mechanisms of DNA breaks and rearrangements in normal and cancer cells. He has been elected to the U.S. National Academy of Sciences, the U.S. National Academy of Medicine, and the European Molecular Biology Organization. His awards include the Albert Szent-Gyorgyi Prize for Progress in Cancer Research, the Novartis Prize for Basic Immunology, the Lewis S. Rosensteil Prize for Distinugished work in Biomedical Sciences, the Paul Berg and Arthur Kornberg Lifetime Achievement Award in Biomedical Sciences, and the William Silan Lifetime Achievement Award in Mentoring from Harvard Medical School.